CD8+ T-cell responses to latency-phase proteins expressed by EBV+ve lymphomas, such as EBNA-1, are reduced in patients with endemic Burkitt’s lymphoma (BL), whereas responses to lytic or latency phase proteins not expressed by the tumors are preserved (18). This evidence concerns the gene CD8A and lymphoma.